Biomedicine & Pharmacotherapy (Apr 2021)

Crosstalk between PPARs and gut microbiota in NAFLD

  • Liwei Wu,
  • Jingjing Li,
  • Jiao Feng,
  • Jie Ji,
  • Qiang Yu,
  • Yan Li,
  • Yuanyuan Zheng,
  • Weiqi Dai,
  • Jianye Wu,
  • Chuanyong Guo

Journal volume & issue
Vol. 136
p. 111255

Abstract

Read online

Nonalcoholic fatty liver disease (NAFLD) has become the most common liver disorder in both China and worldwide. It ranges from simple steatosis and progresses over time to nonalcoholic steatohepatitis (NASH), advanced liver fibrosis, cirrhosis, or hepatocellular carcinoma(HCC). Furthermore, NAFLD and its complications impose a huge health burden to society. The microbiota is widely connected and plays an active role in human physiology and pathology, and it is a hidden ‘organ’ in determining the state of the host, in terms of homeostasis, or disease. Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptorsuperfamily and can regulate multiple pathways involved in metabolism, and serve as effective targets forthe treatment of many types of metabolic syndromes, including NAFLD. The purpose of this review is to integrate related articles on gut microbiota, PPARs and NAFLD, and present a balanced overview on how the microbiota can possibly influence the development of NAFLD through PPARs.

Keywords